e-learning
resources
Breathe
2019
Login
Advanced search
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
VALUE-Dx
Courses and events
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
Andrew W. Creamer, Alice E. Kent, Maha Albur
Source:
Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrew W. Creamer, Alice E. Kent, Maha Albur. Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy. Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
COVID-19 infection and smoking: Myths and reality
Obtaining a grant to organize an ERS Research Seminar
Mechanical ventilation in interstitial lung disease
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
VALUE-Dx
Login